Search Results - "Weston, Rebekah"

PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults by Fenwick, Nicola, Weston, Rebekah, Wheatley, Keith, Hodgson, Jodie, Marshall, Lynley, Elliott, Martin, Makin, Guy, Ng, Antony, Brennan, Bernadette, Lowis, Stephen, Adamski, Jenny, Kilday, John Paul, Cox, Rachel, Gattens, Mike, Moore, Andrew, Trahair, Toby, Ronghe, Milind, Campbell, Martin, Campbell, Helen, Williams, Molly W, Kirby, Maria, Van Eijkelenburg, Natasha, Keely, Jennifer, Scarpa, Ugo, Stavrou, Victoria, Fultang, Livingstone, Booth, Sarah, Cheng, Paul, De Santo, Carmela, Mussai, Francis

“…The survival for many children with relapsed/refractory cancers remains poor despite advances in therapies. Arginine metabolism plays a key role in the…”
Get full text

BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial by Gray, Juliet, Moreno, Lucas, Weston, Rebekah, Barone, Giuseppe, Rubio, Alba, Makin, Guy, Vaidya, Sucheta, Ng, Antony, Castel, Victoria, Nysom, Karsten, Laureys, Genevieve, Van Eijkelenburg, Natasha, Owens, Cormac, Gambart, Marion, Pearson, Andrew DJ, Laidler, Jennifer, Kearns, Pamela, Wheatley, Keith

“…10002 Background: The BEACON phase II trial (NCT02308527) addressed a number of questions in children with relapsed/refractory high-risk neuroblastoma…”
Get full text

Bevacizumab, Irinotecan, or Topotecan added to Temozolomide for children with relapsed and refractory neuroblastoma: Results of the ITCC-SIOPEN BEACON-euroblastoma trial by Moreno, Lucas, Weston, Rebekah, Owens, Cormac, Valteau-Couanet, Dominique, Gambart, Marion, Castel, Victoria, Zwaan, C Michel, Nysom, Karsten, Gerber, Nicolas, Castellano, Aurora, Laureys, Genevieve, Ladenstein, Ruth, Rössler, Jochen, Makin, Guy, Murphy, Dermot, Morland, Bruce, Vaidya, Sucheta, Thebaud, Estelle, van Eijkelenburg, Natasha, Tweddle, Deborah A, Barone, Giuseppe, Tandonnet, Julie, Corradini, Nadege, Chastagner, Pascal, Paillard, Catherine, Bautista, Francisco J, Gallego Melcon, Soledad, de Wilde, Bram, Marshall, Lynley, Gray, Juliet, Burchill, Susan A, Schleiermacher, Gudrun, Chesler, Louis, Peet, Andrew, Leach, Martin O, McHugh, Kieran, Hayes, Roisin, Jerome, Neil, Caron, Hubert, Laidler, Jennifer, Fenwick, Nicola, Holt, Grace, Moroz, Veronica, Kearns, Pamela, Gates, Simon, Pearson, Andrew D J, Wheatley, Keith

“…Purpose: Outcomes for children with relapsed and refractory high-risk neuroblastoma (RR-HRNB) remain dismal. The BEACON Neuroblastoma trial (EudraCT…”
Get full text

Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma: A BEACON-Neuroblastoma biomarker study by Moreno, Lucas, Weston, Rebekah, Viprey, Virginie, Tchirkov, Andrei, Corrias, Maria, Lammens, Tim, Gray, Juliet, Owens, Cormac, Laidler, Jennifer, Gambart, Marion, Castel, Victoria, Van Eijkelenburg, Natasha, Nysom, Karsten, Laureys, Genevieve, Castellano, Aurora, Gerber, Nicolas U., Ladenstein, Ruth Lydia, Valteau Couanet, Dominique, Wheatley, Keith, Burchill, Susan A

“…10039 Background: Children with relapsed and refractory neuroblastoma (RR-NBL) have poor outcomes. Early identification of children at greatest risk of relapse…”
Get full text

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial by Moreno, Lucas, Weston, Rebekah, Owens, Cormac, Valteau-Couanet, Dominique, Gambart, Marion, Castel, Victoria, Zwaan, C Michel, Nysom, Karsten, Gerber, Nicolas, Castellano, Aurora, Laureys, Genevieve, Ladenstein, Ruth, Rössler, Jochen, Makin, Guy, Murphy, Dermot, Morland, Bruce, Vaidya, Sucheta, Thebaud, Estelle, van Eijkelenburg, Natasha, Tweddle, Deborah A, Barone, Giuseppe, Tandonnet, Julie, Corradini, Nadege, Chastagner, Pascal, Paillard, Catherine, Bautista, Francisco J, Gallego Melcon, Soledad, De Wilde, Bram, Marshall, Lynley, Gray, Juliet, Burchill, Susan A, Schleiermacher, Gudrun, Chesler, Louis, Peet, Andrew, Leach, Martin O, McHugh, Kieran, Hayes, Roisin, Jerome, Neil, Caron, Hubert, Laidler, Jennifer, Fenwick, Nicola, Holt, Grace, Moroz, Veronica, Kearns, Pamela, Gates, Simon, Pearson, Andrew D J, Wheatley, Keith

“…Outcomes for children with relapsed and refractory high-risk neuroblastoma (RR-HRNB) remain dismal. The BEACON Neuroblastoma trial (EudraCT 2012-000072-42)…”
Get full text